Collaboration with Gastroenterology in Management of Complex Dysphagia
AbstractPurpose of ReviewTo review common patient populations who present with dysphagia to an otolaryngology office and that may benefit from co-management with a gastroenterologist. These patients include those with gastroesophageal reflux disease, head and neck cancer, allergies/atopic disease, autoimmune conditions, and a normal/straightforward workup for dysphagia.Recent FindingsThe additional diagnostic tests that can be offered by a gastroenterologist beyond an upper endoscopy include high-resolution manometry, functional luminal imaging probe, and mucosal impedance testing. Pharmacologic therapies, as well as endos...
Source: Current Otorhinolaryngology Reports - December 1, 2023 Category: ENT & OMF Source Type: research
Venous air emboli during esophagoscopy confirmed by computed tomographic pulmonary angiography: a case report
CONCLUSION: Timely recognition of VAE, resulting in appropriate interventions supported by CTPA, resulted in favorable patient outcomes.PMID:38029795 | DOI:10.4097/kja.23722 (Source: Korean Journal of Anesthesiology)
Source: Korean Journal of Anesthesiology - November 29, 2023 Category: Anesthesiology Authors: Thadakorn Tantisarasart Thara Tantichamnankul Chanatthee Kitsiripant Panjai Choochuen Source Type: research
Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis
ConclusionsNADAs in patients with FAP frequently become exacerbated. Our findings suggest that patients with FAP who develop duodenal adenomas should be surveyed to prevent the development of duodenal cancer. (Source: Hereditary Cancer in Clinical Practice)
Source: Hereditary Cancer in Clinical Practice - November 27, 2023 Category: Cancer & Oncology Source Type: research
Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker
Intern Med. 2023 Nov 27. doi: 10.2169/internalmedicine.2857-23. Online ahead of print.ABSTRACTA 52-year-old man who had been using a proton pump inhibitor (PPI) and a potassium-competitive acid blocker (P-CAB) for 14 years underwent esophagogastroduodenoscopy and was found to have three neuroendocrine tumors (NETs) in the gastric body. Following detailed examinations, parietal cell dysfunction was excluded, and the NETs did not meet the criteria for the Rindi classification types I-III. The lesions were ultimately considered to be associated with the long-term use of the PPI and P-CAB. We performed endoscopic submucosal di...
Source: Internal Medicine - November 26, 2023 Category: Internal Medicine Authors: Soichiro Nagao Yohei Yabuuchi Kosuke Tanaka Yoshiki Morihisa Takuya Kobayashi Shinsuke Akiyama Gensho Tanke Masaya Wada Shuko Morita Satoko Inoue Hiroshi Tei Daisuke Yamashita Tetsuro Inokuma Source Type: research
